Bipartisan Group Of 243 Lawmakers To HHS: Stop Rx Makers’ 340B Limits

By Michelle M. Stein / September 14, 2020 at 8:36 PM
Updated Story A bipartisan group of more than 240 House lawmakers told HHS Secretary Alex Azar on Monday (Sept. 14) that if he doesn’t stop drug makers from limiting 340B discounts available through contract pharmacies or pushing for extra claims data from those pharmacies, then drug prices will go up for safety net hospitals as other drug makers follow the example of Lilly, AstraZeneca, Sanofi and Merck. “The actions of these companies violate the 340B statute and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.